Enjoy 10% off for Patient Appreciation Day with code THANKYOU10 on 10/15/2026 only! Shop Now >

Enjoy 10% off for Patient Appreciation Day with code THANKYOU10 on 10/15/2026 only! Shop Now >
Breast Cancer awareness starts with prevention.
GLP-1 stands for glucagon-like peptide-1, a hormone your body produces naturally after eating that helps regulate blood sugar, signals fullness and slows digestion. GLP-1 receptor agonist medications mimic this hormone and have become one of the most widely discussed categories in weight management. Because these medications target specific hormonal and metabolic pathways, they are often discussed alongside a broader evaluation of the root causes of weight gain, including insulin resistance and other hormonal factors. These prescription medications work through multiple pathways, including activating receptors in the brain that help reduce appetite and food cravings, slowing gastric emptying to promote a prolonged sense of fullness and enhancing insulin secretion when blood sugar levels are elevated. GLP-1 medications are typically prescribed for adults with type 2 diabetes or for adults managing obesity or overweight with at least one weight-related health condition. Not everyone is a candidate, and a thorough evaluation by a healthcare provider is essential before beginning any GLP-1 treatment. Most GLP-1 medications are administered as subcutaneous injections with dosing that ranges from daily to once weekly, and providers typically start at a lower dose that is gradually increased over time. As a 503A compounding pharmacy, Pharmacy Solutions works alongside healthcare providers to support individualized weight management plans, including customized formulations when appropriate. The Transform Medical Weight Loss Program is also available through Pharmacy Solutions for patients seeking a structured, provider-guided approach. Over-the-counter supplements such as ProBalance Pro-Peptide, Pro-Balance Pro-DIM, ProBalance Green Tea-70 EGCG, Pro-Balance Pro-Glucose Support, Pro-Balance ALA 300 Alpha Lipoic Acid, Pro-Balance L-Glutamine and Metagenics UltraFlora Control are available for purchase without a prescription and may complement a broader wellness plan when discussed with a healthcare provider.
I had so many questions about the medications I was hearing about. Having a pharmacy team that took the time to explain how everything worked and stayed in touch with my provider gave me confidence that I was in good hands.
GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally produces after eating. It helps regulate blood sugar, signals fullness and slows digestion. GLP-1 receptor agonist medications mimic this hormone’s effects and have been studied for their roles in both blood sugar management and weight management. A healthcare provider can explain whether these medications may be relevant to your situation.
GLP-1 receptor agonists work through multiple pathways. They activate receptors in the brain that help reduce appetite and food cravings, slow gastric emptying to promote fullness, enhance insulin secretion when blood sugar is elevated and suppress glucagon release. These combined effects can support weight management when used as part of a provider-guided care plan.
GLP-1 medications are a class of prescription drugs that mimic the body’s natural GLP-1 hormone. Most are administered as subcutaneous injections using prefilled pen devices, with dosing that ranges from daily to once weekly depending on the specific medication. Some oral formulations are also available. Your healthcare provider will determine which option is appropriate for you.
GLP-1 medications are generally prescribed for adults with type 2 diabetes or adults with obesity or overweight who also have at least one weight-related health condition. Not everyone is a candidate. Individuals with certain thyroid conditions, a history of pancreatitis or other specific medical concerns may not be appropriate candidates. A thorough evaluation by a healthcare provider is required.
The most commonly reported side effects include nausea, vomiting, diarrhea and constipation. These effects are often temporary and tend to improve as the body adjusts to the medication. Providers typically start with a lower dose and gradually increase it to help minimize these effects. Your healthcare provider can discuss the full range of potential side effects based on the specific medication being considered.
Yes. A 503A compounding pharmacy can prepare customized medications based on a provider’s prescription when standard commercial options are not the right fit. Pharmacy Solutions works directly with healthcare providers to ensure each preparation meets the individual patient’s needs in the appropriate strength, combination and dosage form.
The Transform Medical Weight Loss Program is a structured, provider-guided weight management program available through Pharmacy Solutions. It connects patients with trained providers who develop customized protocols based on comprehensive clinical assessment. Transform is not a diet and does not recommend surgery. It uses science-based approaches tailored to each individual.
[1] Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism. 2018;27(4):740-756. https://pubmed.ncbi.nlm.nih.gov/29617641/
[2] Cleveland Clinic. GLP-1 agonists: What they are, how they work and side effects. 2024. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
[3] Muller TD, et al. Mechanisms of GLP-1 receptor agonist-induced weight loss: A review of central and peripheral pathways in appetite and energy regulation. American Journal of Medicine. 2024. https://www.sciencedirect.com/science/article/pii/S0002934324007132
[4] Blundell J, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism. 2017;19(9):1242-1251. https://pubmed.ncbi.nlm.nih.gov/28266779/
[5] Garvey WT, et al. American Association of Clinical Endocrinology consensus statement on the comprehensive type 2 diabetes management algorithm. Endocrine Practice. 2023;29(5):305-340. https://pubmed.ncbi.nlm.nih.gov/37150579/
[6] Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384:989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
Tell us a little about what you are looking for and we will take it from there. Whether you have a prescription ready, questions about a therapy your provider mentioned, or just need help figuring out your next step, our team is here and ready to help.
"*" indicates required fields
To submit your order, click the “PRINT/SAVE” button located under this pop-up.Â
You can save the PDF to your computer to fax at a later date or print it now to fax immediately. Â
Fax your order form to 817-860-6083 for processing.
Get detailed information, research, and deeper product context. Toggle on to see more educational content.
Keep things brief and see related products faster. Toggle on to focus on products.
New to Pharmacy Solutions? Register now